Comparison of Infasurf (calf lung surfactant extract) to Survanta (Beractant) in the treatment and prevention of respiratory distress syndrome.

Bloom, B T; Kattwinkel, J; Hall, R T; Delmore, P M; Egan, E A; Trout, J R; Malloy, M H; Brown, D R; Holzman, I R; Coghill, C H; Carlo, W A; Pramanik, A K; McCaffree, M A; Toubas, P L; Laudert, S; Gratny, L L; Weatherstone, K B; Seguin, J H; Willett, L D; Gutcher, G R; Mueller, D H; Topper, W H

Bloom, B T; Kattwinkel, J; Hall, R T; Delmore, P M; Egan, E A; Trout, J R; Malloy, M H; Brown, D R; Holzman, I R; Coghill, C H; Carlo, W A; Pramanik, A K; McCaffree, M A; Toubas, P L; Laudert, S; Gratny, L L; Weatherstone, K B; Seguin, J H; Willett, L D; Gutcher, G R; Mueller, D H; Topper, W H.

Affiliation

Bloom BT; Columbia Wesley Medical Center and University of Kansas School of Medicine-Wichita, Wichita, Kansas 67214, USA.

Pediatrics ; 100(1): 31-8, 1997 Jul.

Article in En | MEDLINE | ID: mdl-9200357

Subject(s)

Biological Products; Pulmonary Surfactants/therapeutic use; Respiratory Distress Syndrome, Newborn/drug therapy; Age Factors; Apgar Score; Birth Weight; Double-Blind Method; Female; Gestational Age; Humans; Infant, Newborn; Infant, Small for Gestational Age; Male; Prospective Studies; Pulmonary Surfactants/administration & dosage; Pulmonary Surfactants/adverse effects; Respiratory Distress Syndrome, Newborn/prevention & control

Search on Google

Add to My VHL

XML

PubMed Links

Collection: 01-internacional Database: MEDLINE Main subject: Respiratory Distress Syndrome, Newborn / Biological Products / Pulmonary Surfactants Type of study: Clinical_trials / Observational_studies / Risk_factors_studies Limits: Female / Humans / Male / Newborn Language: En Journal: Pediatrics Year: 1997 Document type: Article Affiliation country: United States Country of publication: United States

Search on Google

Add to My VHL

XML

PubMed Links